West Pharmaceutical Services, Inc.
WST
株式のランク
#891
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
株価
$382.91
時価総額
$26.95B
変化（1日）
-0.15%
変化（1年）
41.50%
国
US
取引 West Pharmaceutical Services, Inc. (WST)
カテゴリー
Healthcare
West Pharmaceutical Services, Inc.（WST）の営業利益率
October 2026 時点の営業利益率 TTM: 20.64%
West Pharmaceutical Services, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 20.64% です。2023 年末時点では 24.09% でした。
West Pharmaceutical Services, Inc. の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 20.64% | 0.39% |
| 2024 | 20.56% | -14.65% |
| 2023 | 24.09% | -8.96% |
| 2022 | 26.46% | -1.27% |
| 2021 | 26.80% | 37.30% |
| 2020 | 19.52% | 21.09% |
| 2019 | 16.12% | 8.70% |
| 2018 | 14.83% | 3.34% |
| 2017 | 14.35% | 0.49% |
| 2016 | 14.28% | 58.84% |
| 2015 | 8.99% | -29.71% |
| 2014 | 12.79% | 11.70% |
| 2013 | 11.45% | 6.22% |
| 2012 | 10.78% | 10.91% |
| 2011 | 9.72% | 1.25% |
| 2010 | 9.60% | -4.38% |
| 2009 | 10.04% | -15.27% |
| 2008 | 11.85% | 6.95% |
| 2007 | 11.08% | -4.24% |
| 2006 | 11.57% | 10.61% |
| 2005 | 10.46% | -11.36% |
| 2004 | 11.80% | 6.21% |
| 2003 | 11.11% | 74.69% |
| 2002 | 6.36% | -38.90% |
| 2001 | 10.41% | 25.42% |
| 2000 | 8.30% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 31.28% | -98.48% |
US
|
|
| 12.36% | -99.40% |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | -99.52% |
US
|
|
| 0.00% | - |
CH
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。